METHOD FOR PREDICTING NEPHROGENOUS HYPERTENSION DEVELOPMENT IN CHILDREN SUFFERING FROM GLOMERULONEPHRITIS Russian patent published in 2004 - IPC

FIELD: medicine.

SUBSTANCE: method involves carrying out medical and biological clinical laboratory examination and analysis of data received. The medical and biological under study comprise perinatal anamnesis, genealogical anamnesis on hypertension disease, gastrointestinal tract diseases, allergic disease, blood group, body mass index after Kettle-2, concomitant pathologies availability like adiposity, chronic gastroduodenitis and biliary tracts dyskinesia, chronic viral hepatitis of type B or C as well as clinical laboratory examination data like the number of eosinophils, erythrocytes, amount of hemoglobin, creatinine and urease in peripheral blood, daily uricosuria and proteinuria. Protracted labors with their increase, aggravated genealogic anamnesis on hypertension, gastrointestinal tract diseases, allergic disease, blood group A(II), body mass index after Kettle-2 being found higher than 75 percentile, concomitant pathology availability like adiposity, chronic gastroduodenitis and biliary tracts dyskinesia, chronic viral hepatitis of type B or C, creatinine and urease content above 104.2 mcmole/l and 9.3 mmole/l, respectively, the number of blood erythrocytes, eosinophils, amount of hemoglobin below 3.5*10¹²/l, 4.8%, 113.6 g/l, respectively as well as daily uricosuria above age-specific level and daily proteinuria above 2.67 g/day, nephrogenous hypertension development is predicted in children suffering from glomerulonephritis.

EFFECT: prevented or retarded hypertension development in children.

2 cl, 2 tbl